Patents cover innovations in semiconductor security, cryptographic key management, and anti-tampering mechanisms; see full portfolio here. SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a ...
Set to be issued in February 2025, the patent will expire in 2042 and covers the oral administration of the drug to reduce fat levels and body weight. The US Patent Office has accepted patent ...
The patents cover innovations in semiconductor security, cryptographic key management, and anti-tampering mechanisms. Sealsq’s patents represent a foundation for the future of secure ...
EPO grants Sonnet EU Patent No. EP3583125 B1 for Fully Human Albumin Binding (FHAB®) domain fusion proteins, expanding global IP protection. Sonnet BioTherapeutics Holdings, Inc. announced that ...
The patent covers Beam Global’s Phase Change Composite (PCC™) spacer product for Li-ion battery thermal management and is titled Phase Change Composite Apparatus for Battery Packs and Methods ...
This patent covers additional claims for an enhanced, next-generation version of Allurion’s proprietary Balloon technology and the introduction of innovative features, particularly to the ...
BOSTON, Jan. 8, 2025 /PRNewswire/ -- Connectbase, the global ecosystem for buying and selling connectivity, today announces that the United States Patent and Trademark Office has granted the company ...
The patent covers the oral administration of the drug to treat obesity. Credit: Cynthia A Jackson/Shutterstock. Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for ...
Revenue Minister Chandrashekhar Bawankule told PTI that the probe will cover certificates already issued and applications received. The government's decision to form a probe team follows BJP ...